L-052-2018
Agreement ID
L-052-2018
Lead IC
NCI
Exclusivity
Exclusive
External Party
MedGene Therapeutics, Inc.
Fiscal Year
2023
Territory
Worldwide
Execution Date
Effective Date
Export Date
Technologies